作者：朱迅、丁红霞
页数：348
出版社：中国医药科技出版社
出版日期：2017
ISBN：9787521403176
电子书格式：pdf/epub/txt
内容简介
本书涵盖了筛选的10个优选上市有名单抗药物的临床前及临床核心实验数据（专利、药理学、药代动力学、毒理学和临床），由中国专家团队编著，全英文撰写。
目录
CHAPTER 1 Ado-trasmzumab Emtansine
CHAPTER 2 Atezolizumab
CHAPTER 3 Bevacizumab
CHAPTER 4 Blinatumomab
CHAPTER 5 Cetuximab
CHAPTER 6 Ipilimumab
CHAPTER 7 Ranibizumab
CHAPTER 8 Rituximab
CHAPTER 9 Tocilizumab
CHAPTER 10 Trastuzumab
Appendix I. Abbreviation
Appendix II. Worldwide Approved Monoclonal Antibodies (1982-2017)
CHAPTER 2 Atezolizumab
CHAPTER 3 Bevacizumab
CHAPTER 4 Blinatumomab
CHAPTER 5 Cetuximab
CHAPTER 6 Ipilimumab
CHAPTER 7 Ranibizumab
CHAPTER 8 Rituximab
CHAPTER 9 Tocilizumab
CHAPTER 10 Trastuzumab
Appendix I. Abbreviation
Appendix II. Worldwide Approved Monoclonal Antibodies (1982-2017)
![土地复垦与生态重建专著Landreclamationandecologicalrestoration胡振琪[等]编著-技术教育社区](https://image12.bookschina.com/2025/20250403/1/B9609377.jpg)
